BE1031607B1 - Silice d’origine biologique et utilisations de celle-ci - Google Patents

Silice d’origine biologique et utilisations de celle-ci

Info

Publication number
BE1031607B1
BE1031607B1 BE20235395A BE202305395A BE1031607B1 BE 1031607 B1 BE1031607 B1 BE 1031607B1 BE 20235395 A BE20235395 A BE 20235395A BE 202305395 A BE202305395 A BE 202305395A BE 1031607 B1 BE1031607 B1 BE 1031607B1
Authority
BE
Belgium
Prior art keywords
composition
silica
biobased
relates
mesoporous silica
Prior art date
Application number
BE20235395A
Other languages
English (en)
Other versions
BE1031607A1 (fr
Inventor
Christiaan Willaert
Original Assignee
Silinnov Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silinnov Srl filed Critical Silinnov Srl
Priority to BE20235395A priority Critical patent/BE1031607B1/fr
Priority to EP24724298.5A priority patent/EP4709358A1/fr
Priority to PCT/EP2024/063103 priority patent/WO2024235914A1/fr
Publication of BE1031607A1 publication Critical patent/BE1031607A1/fr
Application granted granted Critical
Publication of BE1031607B1 publication Critical patent/BE1031607B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition comprenant une silice mésoporeuse d’origine biologique présentant une surface spécifique, calculée à partir d’isothermes de sorption d’azote à la température de l’azote liquide (77 K) par la théorie de Brunauer, Emmett et Teller (BET), d’au moins 300 m²/g, dans laquelle ladite silice mésoporeuse est imprégnée avec un composé. De plus, l’invention concerne une forme galénique orale, l’utilisation de ladite composition et un procédé de production de ladite composition.
BE20235395A 2023-05-12 2023-05-12 Silice d’origine biologique et utilisations de celle-ci BE1031607B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BE20235395A BE1031607B1 (fr) 2023-05-12 2023-05-12 Silice d’origine biologique et utilisations de celle-ci
EP24724298.5A EP4709358A1 (fr) 2023-05-12 2024-05-13 Silice biosourcée et ses utilisations
PCT/EP2024/063103 WO2024235914A1 (fr) 2023-05-12 2024-05-13 Silice biosourcée et ses utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20235395A BE1031607B1 (fr) 2023-05-12 2023-05-12 Silice d’origine biologique et utilisations de celle-ci

Publications (2)

Publication Number Publication Date
BE1031607A1 BE1031607A1 (fr) 2024-12-06
BE1031607B1 true BE1031607B1 (fr) 2024-12-11

Family

ID=87569915

Family Applications (1)

Application Number Title Priority Date Filing Date
BE20235395A BE1031607B1 (fr) 2023-05-12 2023-05-12 Silice d’origine biologique et utilisations de celle-ci

Country Status (3)

Country Link
EP (1) EP4709358A1 (fr)
BE (1) BE1031607B1 (fr)
WO (1) WO2024235914A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3381457A1 (fr) * 2017-03-28 2018-10-03 Natural Products & Drugs GmbH Composition physiologique active contenant de la n-acétylglucosamine pour le traitement de la douleur dorsale
US20200246469A1 (en) * 2019-02-05 2020-08-06 Griffith Foods International Inc. Anti-caking and flow agents for dry powdered foods, food ingredients, pharmaceuticals and nutraceuticals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3381457A1 (fr) * 2017-03-28 2018-10-03 Natural Products & Drugs GmbH Composition physiologique active contenant de la n-acétylglucosamine pour le traitement de la douleur dorsale
US20200246469A1 (en) * 2019-02-05 2020-08-06 Griffith Foods International Inc. Anti-caking and flow agents for dry powdered foods, food ingredients, pharmaceuticals and nutraceuticals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHOU-CANG SHEN ET AL: "Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 99, no. 4, 1 January 2009 (2009-01-01), pages n/a - n/a, XP055075670, ISSN: 0022-3549, DOI: 10.1002/jps.21967 *

Also Published As

Publication number Publication date
EP4709358A1 (fr) 2026-03-18
WO2024235914A1 (fr) 2024-11-21
BE1031607A1 (fr) 2024-12-06

Similar Documents

Publication Publication Date Title
Al-Majed et al. Propranolol
BE1031607B1 (fr) Silice d’origine biologique et utilisations de celle-ci
Theodore et al. Stereospecific synthesis of the enantiomers of verapamil and gallopamil
BR0214000A (pt) Método de sìntese de metaloaluminofosfato (elapo) microporoso cristalino a partir de um corpo sólido, e, uso de partìculas
EP2521720B1 (fr) Nouveau procédé d'élaboration de dronédarone
CA2564367A1 (fr) Forme cristalline .delta. du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
ZA202305590B (en) Crystal form iv of melanocortin receptor agonist compound, and preparation method therefor
AU3008501A (en) Method for producing alkali methylates
ATE513823T1 (de) Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung
RU2010116172A (ru) Способ инициирования высокоселективного катализатора получения этиленоксида
Smith et al. The Diastereomeric Menthyl Chlorides Obtained from (--) Menthol
ES2194965T3 (es) Instalacion de destilacion.
NO854036L (no) Tetrahydronaftalinderivater.
Shakhmaev et al. Iron-catalyzed synthesis of cinnarizine
CA2491644A1 (fr) Procede de cristallisation fractionnee d'un metal en fusion
CA2359825A1 (fr) Tamis moleculaire mesoporeux a base d'aluminium et methode de preparation connexe
JP4649813B2 (ja) ２−アミノ−４−（４−フルオロフェニル）−６−アルキルピリミジン−５−カルボキシレートの製造方法
BRPI0620608A2 (pt) processo para produção de óxido de propileno
DE69308222T2 (de) Katalysator zur asymmetrischen Induktion
McHale et al. Chlorine (III) oxide, a new chlorine oxide
CN108675972B (zh) 一种盐酸胺碘酮中间体2-丁基苯并呋喃的制备方法
GB1021387A (en) Improvements in or relating to dithiazolium salts
ES2337452T3 (es) Proceso para la preparacioon de ciclododecanona.
EP2661323A1 (fr) Procédé de production d'un oxyde d'oléfine
BR0204885A (pt) Processo para produção de ácidos carboxìlicos saturados com um a quatro átomos de c, por oxidação de fase gasosa de 2-butanona

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20241211